In addition, PIPKIα and IPMK expression was significantly elevated and correlated with CTGF expression in breast cancer clinical samples, making PIPKIα and IPMK promising drug targets in YAP/TAZ-driven breast and other cancers. This evidence concerns the gene IPMK and breast carcinoma.